Company Filing History:
1 out of 1 
1 out of 14 
Years Active: 2021
Title: The Innovative Contributions of Jeffrey Ecsedy
Introduction
Jeffrey Ecsedy is a notable inventor based in Boston, MA. He has made significant contributions to the field of immuno-oncology through his innovative research and development. His work focuses on the use of EP4 inhibitors for cancer treatment, showcasing his commitment to advancing medical science.
Latest Patents
Ecsedy holds a patent for "EP4 inhibitors and use thereof." This invention provides the use of an agent that inhibits EP4 activity, along with an immuno-oncology agent or a composition thereof, for the treatment of cancer. This patent highlights his dedication to finding new therapeutic approaches in oncology.
Career Highlights
Throughout his career, Jeffrey Ecsedy has worked with several prominent companies, including Arrys Therapeutics, Inc. and Askat Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to the advancement of cancer treatment.
Collaborations
Ecsedy has collaborated with notable professionals in his field, including Mark Manfredi and Atsushi Nagahisa. These partnerships have further enriched his research and development efforts, leading to impactful innovations.
Conclusion
Jeffrey Ecsedy's work in the field of immuno-oncology exemplifies the importance of innovation in medical science. His contributions, particularly through his patent on EP4 inhibitors, demonstrate his commitment to improving cancer treatment options.